Activity-dependent phosphorylation of CDYL by CDK5 regulates fear memory in mice.

IF 6.2 1区 医学 Q1 PSYCHIATRY
Na-Yun Lyu, Guo-Guang Xie, Zhi-Wen Hu, Tian-Jie Lyu, Rui Qin, Lu Chen, Yun Wang
{"title":"Activity-dependent phosphorylation of CDYL by CDK5 regulates fear memory in mice.","authors":"Na-Yun Lyu, Guo-Guang Xie, Zhi-Wen Hu, Tian-Jie Lyu, Rui Qin, Lu Chen, Yun Wang","doi":"10.1038/s41398-025-03568-0","DOIUrl":null,"url":null,"abstract":"<p><p>Fear memory is crucial for animals to effectively respond to dynamic environments and survive dangerous stimuli. However, aberrant fear memory contributes to various psychiatric disorders, such as post-traumatic stress disorder (PTSD). Despite its importance, the precise molecular mechanisms underlying fear memory remain insufficiently understood. In this study, we highlight the pivotal role of the epigenetic factor chromodomain Y-like protein (CDYL) in the regulation of fear memory. We discovered that ablation of CDYL in CaMKIIα<sup>+</sup> excitatory neurons in the forebrain or hippocampus leads to increased fear memory in mice. CDYL is phosphorylated by cyclin-dependent kinase 5 (CDK5) at Ser147, which facilitates tripartite motif containing 32 (TRIM32)-mediated ubiquitination and degradation of CDYL in response to neural activity. Additionally, we developed an interfering peptide that specifically targets the phosphorylation of CDYL at Ser147, resulting in a decrease in contextual fear memory in mice. Collectively, our findings underscore the essential role of CDYL in fear memory and illustrate the modulatory function of CDK5 and TRIM32 on CDYL, positioning CDYL as a promising target for the modulation of fear memory.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"15 1","pages":"334"},"PeriodicalIF":6.2000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12398608/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-025-03568-0","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Fear memory is crucial for animals to effectively respond to dynamic environments and survive dangerous stimuli. However, aberrant fear memory contributes to various psychiatric disorders, such as post-traumatic stress disorder (PTSD). Despite its importance, the precise molecular mechanisms underlying fear memory remain insufficiently understood. In this study, we highlight the pivotal role of the epigenetic factor chromodomain Y-like protein (CDYL) in the regulation of fear memory. We discovered that ablation of CDYL in CaMKIIα+ excitatory neurons in the forebrain or hippocampus leads to increased fear memory in mice. CDYL is phosphorylated by cyclin-dependent kinase 5 (CDK5) at Ser147, which facilitates tripartite motif containing 32 (TRIM32)-mediated ubiquitination and degradation of CDYL in response to neural activity. Additionally, we developed an interfering peptide that specifically targets the phosphorylation of CDYL at Ser147, resulting in a decrease in contextual fear memory in mice. Collectively, our findings underscore the essential role of CDYL in fear memory and illustrate the modulatory function of CDK5 and TRIM32 on CDYL, positioning CDYL as a promising target for the modulation of fear memory.

CDK5介导的CDYL活性依赖性磷酸化调节小鼠的恐惧记忆。
恐惧记忆对动物有效应对动态环境和生存危险刺激至关重要。然而,异常的恐惧记忆会导致各种精神疾病,如创伤后应激障碍(PTSD)。尽管它很重要,但恐惧记忆背后的精确分子机制仍然没有得到充分的理解。在这项研究中,我们强调了表观遗传因子染色体结构域y样蛋白(CDYL)在恐惧记忆调节中的关键作用。我们发现,切除小鼠前脑或海马CaMKIIα+兴奋性神经元中的CDYL可导致小鼠恐惧记忆增加。CDYL在Ser147位点被细胞周期蛋白依赖性激酶5 (CDK5)磷酸化,这促进了TRIM32介导的CDYL泛素化和降解,以响应神经活动。此外,我们开发了一种干扰肽,专门针对CDYL的Ser147磷酸化,导致小鼠情境恐惧记忆的减少。总之,我们的研究结果强调了CDYL在恐惧记忆中的重要作用,并阐明了CDK5和TRIM32对CDYL的调节功能,将CDYL定位为调节恐惧记忆的有希望的靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
11.50
自引率
2.90%
发文量
484
审稿时长
23 weeks
期刊介绍: Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信